Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

GNF-5837

SKU: orb1301076

Description

GNF-5837 is a potent, orally active pan-TRK inhibitor targeting TrkA and TrkB with IC50 values of 8 nM and 12 nM, respectively. It is a valuable research tool for investigating TRK kinase signaling in cancer and neurological disease models, both in vitro and in vivo.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

Key Properties

CAS Number1033769-28-6
MW535.49
Purity99.29% (May vary between batches)
FormulaC28H21F4N5O2
SMILESCc1ccc(NC(=O)Nc2cc(ccc2F)C(F)(F)F)cc1Nc1ccc2\C(=C\c3ccc[nH]3)C(=O)Nc2c1
TargetTrk receptor,c-Kit,PDGFR
SolubilityDMSO:40 mg/mL (74.7 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.73 mM);Ethanol:5.4 mg/mL (10.08 mM)

Bioactivity

Target IC50
TrkC:7 nM|TrkB:12 nM|TrkA:8 nM
In Vivo
In both male Balb/c mice and Sprague–Dawley rats, GNF-5837 has the low drug clearance, and moderate biovailability. In mice bearing Rie xenografts expressing TrkA and NGF, GNF-5837 (100 mg/kg/d p.o.) significantly inhibits tumor growth.
In Vitro
In Ba/F3 cells overexpressing the constitutively active Tel-TRKC fusion, GNF-5837 shows potent anti-Trk activity and potent antiproliferation activity with IC50 of 0.042 μM.
Cell Research
Compounds are tested for their ability to inhibit the proliferation of wt Ba/F3 cells and Ba/F3 cells transformed with constitutively expressed luciferase reporter and BCR-ABL or Tel-KDR or other Tel fusion kinases. Parental Ba/F3 cells are maintained in media containing recombinant mouse IL3 and the kinase transformed Ba/F3 cells are maintained in media without IL-3. 7.5 nL of compounds are spotted to each well of 1536-well assay plates by Liquid handling System Echo 555 (Labcyte). 700 cells are then plated into each well of the assay plates in 7 μL culture media per well and compounds are tested at 0.17 nM to 10 uM in 3-fold serial dilutions. The cells were then incubated for 48 hours at 37 °C. 3 μL of Bright-Glo® is added to each well and the plates are read using ViewLux. (Only for Reference)

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

cKit, Inhibitor, GNF5837, GNF-5837, GNF 5837, Kit, inhibit, PDGFRβ, Tropomyosin related kinase receptor, Trk receptor, Trk Receptor, TrkA, TrkC, TrkB, Trkreceptor

Similar Products

  • GNF-5837 [orb1222917]

    >98% (HPLC)

    1033769-28-6

    535.49

    C28H21F4N5O2

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

5 mg
$ 90.00
1 ml x 10 mM (in DMSO)
$ 100.00
10 mg
$ 120.00
25 mg
$ 170.00
50 mg
$ 240.00
100 mg
$ 370.00
200 mg
$ 470.00
500 mg
$ 740.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry